EMBO at Basel Life

A new conference on current and emerging life science research

14-Sep-2017 - EMBO and Basel Life hosted EMBO at Basel Life conference. A committee of leading scientists had organized this international and broad-scope scientific conference on current and emerging life science research to be held as part of Basel Life. “Established and young researchers will present and ...

A patent-free playground

Researchers and industrial companies collaborate to create a new Open Science platform

01-Aug-2017 - Along with a number of leading Danish industrial companies, Aarhus University has opted out of the patent rat race in a new collaboration on industrially relevant basic research. Researchers and companies from all over Denmark publish all their results and data on the innovative Open Science ...

Basic research fuels advanced discovery

29-Aug-2016 - Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says UC Santa Barbara neuroscientist Kenneth S. Kosik. In fact supporting ...

New cancer immunotherapy approach combines tumor fighting power with fewer side effects

18-May-2016 - Basic research into the dual nature of certain immune system cells has set the stage for a new approach to cancer immunotherapy that avoids some of the shortcomings associated with other methods, scientists at Dana-Farber Cancer Institute report in a new study in the Proceedings of the National ...

Molecular simulations confirm role of functional rotation in multidrug resistance

22-Nov-2010 - A new molecular simulation technique developed by researchers at RIKEN and Kyoto University has confirmed for the first time the function of the transporter protein AcrB in E. coli multidrug resistance. The result marks a key step in efforts to combat antibiotic resistance, demonstrating the ...

Cooperation in diabetes research

Max Planck Institute of Biochemistry and GlaxoSmithKline in collaboration on type II diabetes

21-Oct-2010 - The Max Planck Institute (MPI) of Biochemistry in Martinsried and pharmaceutical company GlaxoSmithKline GmbH & Co. KG (GSK) have signed a research agreement on the development of new drugs for the treatment of type II diabetes. The cooperation agreement, negotiated with the help of technology ...

MDxHealth Outlines New Strategy

Focus on molecular diagnostic testing for personalized medicine in oncology

20-Oct-2010 - MDxHealth, formerly known as OncoMethylome Sciences, announced further details regarding its revised business strategy. For the past several months, MDxHealth’s management has worked very closely with the Board of Directors to define a strategic path to accelerate growth and monetization of the ...

caprotec bioanalytics appoints Prof. Dr. Metternich as Managing Director, Chief Business Officer and Chief Operating Officer

06-Oct-2010 - caprotec bioanalytics GmbH announced the appointment of Prof. Dr. Rainer Metternich as Managing Director, Chief Business Officer and Chief Operating Officer of the company. Prior to joining caprotec, Prof. Metternich held senior leadership positions at Merck & Co., Schering AG and ...

The Nobel Prize in Physiology or Medicine 2010 goes to Robert G. Edwards for the development of in vitro fertilization

04-Oct-2010 - Robert Edwards is awarded the 2010 Nobel Prize for the development of human in vitro fertilization (IVF) therapy. His achievements have made it possible to treat infertility, a medical condition afflicting a large proportion of humanity including more than 10% of all couples worldwide. As early ...

Specialist Business Unit of the University of Nottingham Spins-Out to Form New R&D Oncology Company

13-Sep-2010 - Preclinical Oncology Services Limited (PRECOS), a pre-clinical research and development service with a specific focus on oncology, announced its official launch following its spin-out from the University of Nottingham. The newly formed company combines the innovation of one of the university with ...